0001483426-22-000001.txt : 20220303 0001483426-22-000001.hdr.sgml : 20220303 20220303114802 ACCESSION NUMBER: 0001483426-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220303 DATE AS OF CHANGE: 20220303 EFFECTIVENESS DATE: 20220303 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MBio Diagnostics, Inc. CENTRAL INDEX KEY: 0001483426 IRS NUMBER: 300593627 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-435698 FILM NUMBER: 22707276 BUSINESS ADDRESS: STREET 1: 5603 ARAPAHOE AVENUE STREET 2: SUITE 1 CITY: BOULDER STATE: CO ZIP: 80303 BUSINESS PHONE: 3039522905 MAIL ADDRESS: STREET 1: 5603 ARAPAHOE AVENUE STREET 2: SUITE 1 CITY: BOULDER STATE: CO ZIP: 80303 FORMER COMPANY: FORMER CONFORMED NAME: mBio Diagnostics, Inc. DATE OF NAME CHANGE: 20100204 D 1 primary_doc.xml X0708 D LIVE 0001483426 MBio Diagnostics, Inc. 5603 ARAPAHOE AVENUE SUITE 1 BOULDER CO COLORADO 80303 302-658-7581 DELAWARE mBio Diagnostics, Inc. Corporation true Nick Traggis 5603 Arapahoe Avenue, Suite 1 Boulder CO COLORADO 80303 Executive Officer Director Judith O'Brien 5603 Arapahoe Avenue, Suite 1 Boulder CO COLORADO 80303 Director Michael Chang 5603 Arapahoe Avenue, Suite 1 Boulder CO COLORADO 80303 Director Robert Silverman 5603 Arapahoe Avenue, Suite 1 Boulder CO COLORADO 80303 Director Christopher Myatt 5603 Arapahoe Avenue, Suite 1 Unit 120 Boulder CO COLORADO 80303 Director Andrew Drenick 5603 Arapahoe Avenue, Suite 1 Boulder CO COLORADO 80303 Director Biotechnology Decline to Disclose 06b false 2022-02-18 false true true false 0 9000000 6120000 2880000 The total offering amount includes convertible promissory notes convertible into shares of the company's capital stock. false 12 0 0 0 false MBio Diagnostics, Inc. /s/ Nick Traggis Nick Traggis CEO, by Tyler Hayden, Attorney-in-Fact 2022-03-03